Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s products are commercially available and used as reference methods by the Swiss Federal Institute of Metrology. Their continuous in-situ sensors enable real-time metabolic monitoring of glucose and lactate in cell cultures from small vessels to large-scale bioreactors. This allows automated process control without sampling—reducing contamination risk and improving yields. Their technologies are widely adopted across upstream bioprocessing, cell therapy development, regenerative medicine research, and related fields. No clinical trial results apply as the company provides enabling technologies rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C-CIT Sensors.